90% of the 96 Core Curriculum Sessions Include Presentations from
Institutions Committed to Magnetic Navigation
Stereotaxis to Feature New Odyssey Information Management and Next
Generation Software Products in Booth 304
ST. LOUIS, May 9 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that its participation at Heart Rhythm 2008 reflects the broad market leadership it has achieved as the only provider of fully automated, remote navigation technology for cardiac ablation. Of the 96 core curriculum sessions that represent the principal scientific content of the conference, 90% include presentations by physicians from institutions that have already purchased or ordered a Niobe(R) Magnetic Navigation system. Stereotaxis customers are presenting in all 33 sessions related to ablation techniques. More than 30 presentations that feature clinical applications of Stereotaxis technology, in all four chambers of the heart, will be delivered through the core curriculum, abstracts and poster sessions.
For instance, Marcus Wharton, MD will present on magnetic field-guided ablation for complex arrhythmias at 1:35 pm PDT on May 16; from the lab of Jeremy Ruskin, MD, at Massachusetts General Hospital, Arash Aryana, MD will report on remote, guided magnetic catheter ablation of ventricular tachycardia at 8:25 am on May 15; and Xu Chen, MD from Rigshospitalet in Copenhagen will present on the use of magnetic navigation in the pediatric population.
With this evidence of broad clinical utility as a backdrop, Stereotaxis
plans to highlight the simplicity, safety, and efficacy that are enabled by
its magnetic navigation and information management systems in several
o "The Integrated EP Lab: The Future of Complex Arrhythmia Ablation" --
This accredited symposium sponsored by NACCME with educational support
from Stereotaxis, Biosense Webster an
|SOURCE Stereotaxis, Inc.|
Copyright©2008 PR Newswire.
All rights reserved